UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
MVD-Fonds Rating | EDA |
---|---|
![]() ![]() ![]() ![]() ![]() ![]() | 75 |
ISIN: LU0069152568 | WKN: 986327
KAG: UBS Fund M. (LU)
NAV: 764,58 USD am 21.08.2024
Chart
Kennzahlen UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
Performance | -0,43% | +11,90% | +14,07% | -10,12% | +32,80% | +57,51% | +664,58% |
Volatilität | +20,16% | +19,33% | +20,31% | +22,14% | +23,89% | +24,59% | +27,20% |
Sharpe Ratio | -0,43 | +1,13 | +0,52 | -0,32 | +0,10 | +0,05 | +0,15 |
Bester Monat | - | +9,18% | +15,82% | +15,82% | +15,82% | +15,82% | +41,13% |
Schl. Monat | - | -8,43% | -8,90% | -11,66% | -11,66% | -21,18% | -28,27% |
Max. Verlust | -7,92% | -11,41% | -15,39% | -36,37% | -36,37% | -40,97% | -75,23% |
Monatsperformance UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD
2024 | 2023 | 2022 | 2021 | 2020 | |
Januar | -2,87% | +1,32% | -11,66% | -0,85% | -3,79% |
Februar | -0,65% | -6,03% | -2,71% | -3,31% | +0,14% |
März | +1,77% | +0,80% | +4,10% | -2,99% | -6,99% |
April | -8,43% | +0,63% | -9,90% | +2,18% | +14,55% |
Mai | +9,18% | -2,75% | -3,91% | -1,47% | +10,01% |
Juni | +3,78% | +1,04% | +5,86% | +9,09% | +3,09% |
Juli | +6,78% | +2,67% | +1,43% | -1,56% | -2,92% |
August | -2,00% | -2,00% | +5,19% | +5,14% | -0,79% |
September | - | -4,14% | -0,31% | -6,32% | +0,08% |
Oktober | - | -8,90% | +4,72% | -3,03% | -4,94% |
November | - | +5,02% | +6,94% | -4,24% | +10,70% |
Dezember | - | +15,82% | -6,14% | +2,61% | +5,51% |
Gesamt | +6,63% | +1,42% | -8,32% | -5,64% | +24,59% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (UBS (Lux) Equity Fund - Biotech (USD)) oder suchen Sie weitere Top-Fonds zum Thema Aktien (Branche Biotechnologie) weltweit in USD:
Fonds vergleichenWeitere ähnliche Fonds